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Nrf2 is a transcription factor responsible for gene expression of
a series of anti-oxidant proteins and detoxifying enzymes.
Keap1, an adaptor protein of Cullin-3 ubiquitin ligase, senses
electrophilic or oxidative stresses and then arrests ubiquitina-
tion of Nrf2, leading to Nrf2 activation. In addition to this ca-
nonical pathway, one Nrf2 target (p62/SQSTM1) competitively
binds to Keap1 to activate Nrf2. The p62/SQSTM1-Keap1-Nrf2
axis is linked to selective autophagy and regulated by post-
translational modifications such as sequential phosphorylation
and ubiquitination of p62/SQSTM1. Importantly, this non-
canonical pathway is hyper-activated in autophagy-deficient
mouse livers and tissues of hepatocellular carcinoma. In this
review, we delineate a molecular mechanism of Nrf2-activation
by p62/SQSTM1, and describe its physiological role as well as
the pathophysiological significance in autophagy-knockout
livers and human hepatocellular carcinoma.
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p62/SQSTM1 (hereafter referred to as p62) is a stress-
inducible and multifunctional protein [1,2] with mul-
tiple domains, including a Phox1 and Bem1p (PB1)
domain, a zinc finger (ZZ), two nuclear localization
signals (NLSs), a TRAF6 binding (TB) domain, a nu-
clear export signal (NES), an LC3-interacting region
(LIR), a Keap1-interacting region (KIR), and a
ubiquitin-associated (UBA) domain (Figure 1). While
p62 has been extensively studied as a scaffold protein for
atypical PKC, ERK1, NF-kB, caspase-8, and mTORC1Current Opinion in Toxicology 2016, 1:54–61[3], a growing body of evidence has revealed that p62
serves as an adaptor between selective autophagy and
ubiquitin signaling [4,5]. p62 forms helical filaments
based on a PB1 domain scaffold [6], which easily
aggregate into large structures with ubiquitinated pro-
teins under stress conditions [7e9]. Such p62-aggregate
structures are degraded in an autophagy-dependent
manner [8e10]. p62 is usually accumulated in
autophagy-deficient mouse tissues, and p62-positive
aggregate structures [11*] are a typical feature of
impaired autophagy [12]. Likewise, p62-positive
aggregate structures have been identified in tissues of
human patients, including in association with neurode-
generative diseases, liver disorders, and cancers [13,14].
The Keap1eNrf2 system is a major oxidative stress
response pathway [15,16]. Nuclear factor erythroid 2e
related factor 2 (Nrf2) is a basic leucine zipper (bZIP)
transcription factor, and its heterodimer with small Maf
proteins controls the expression of anti-oxidant proteins
that protect against oxidative damage triggered by injury
and inflammation. Kelch-like ECH-associated protein 1
(Keap1) is an adaptor protein of Cullin-3-based ubiq-
uitin ligase. The Keap1 forms a homodimer that recog-
nizes ETGE and DLGex motifs of one Nrf2 molecule
through the same binding pocket located at the bottom
surface of Keap1 [17e20]. This two-site binding is
indispensable for ubiquitination of Nrf2. While ETGE
tightly binds to Keap1, the binding affinity of DLGex is
much weaker than that of ETGE, and the binding is
quickly dissociated, fine-tuning the ubiquitination of
Nrf2 [19,20]. Upon modification of specific cysteine
residues of Keap1 by oxidants, Nrf2 escapes from the
Keap1 interaction and translocates to the nucleus to
induce Nrf2-target gene expression [21e24]. This
Keap1eNrf2 pathway enables rapid and transient acti-
vation of Nrf2 in response to stressors (Figure 2).2. Molecular mechanism of Nrf2-activation
by p62
Loss of autophagy in mouse livers causes robust Nrf2-
activation, accompanied by severe accumulation of p62
[11*]. Increased oxidative stress due to impaired auto-
phagy was initially assumed to be a primary cause for the
Nrf2-activation, but mass spectrometry analyses by
several independent groups identified the direct inter-
action between p62 and Keap1, which inhibits the
ability of Keap1 to trap Nrf2, followed by Nrf2-
stabilization and activation [25**, 26**, 27]. One Nrf2www.sciencedirect.com
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Schematic domain structures of p62. p62 interacts with p62, NBR1,
ERK1, and atypical PKC (aPKC) through Phox and Bem1 (PB1)-mediated
homooligomerization or heterooligomerization. K7 ubiquitination of PB1,
mediated by TRIM21, inhibits the oligomerization. The zinc finger (ZZ) and
TRAF6-binding domain (TB) interact with the RIP and TRAF6, respec-
tively, to regulate NF-kB signaling. Raptor interacts with the linker region
between ZZ and TB for mTORC1 activation. LC3-interacting region (LIR)
and the C-terminal ubiquitin-associated domain (UBA) engage the
sequestration of ubiquitinated substrates into the autophagosome. Keap1-
interacting region (KIR) binds to Keap1. Phosphorylation of Ser403 and
Ser407 residues on UBA domain and Ser349 residue on KIR occur in
response to selective autophagy. The UBA domain also interacts with
ubiquitinated caspase8 to facilitate the apoptosis signal. NLS and NES
indicate nuclear localization signal and nuclear export signal, respectively.
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and ETGE binding motifs in the Neh2 domain of Nrf2
bind individually to the same binding pocket located at
the bottom surface of Keap1 [19,20,28]. The two-site
substrate recognition mechanism is crucial for the
rapid ubiquitination of lysine residues located between
the DLGex and ETGE motifs [19,20,28]. ETGE binds
tightly to Keap1, whereas the Keap1eDLGex interac-
tion is characterized as “fast-on and fast-off” [20]. X-ray
crystal structural analysis of double glycine repeat and
C-terminal region (DC) domain of Keap1 in complex
with the p62 KIR peptide showed that the KIR peptide
also binds to the bottom of the b-propeller structure
[25**]. Remarkably, p62-KIR binds to Keap1 in a
manner very similar to the Nrf2-ETGE. p62-KIR forms
hydrogen bonds with eight amino acid residues of
Keap1-DC. These eight residues and two additional
Keap1 residues participate in Keap1 recognition of the
Nrf2-ETGE. Therefore, the binding-dissociation con-
stant of Keap1-p62 is lower than that of Nrf2-ETGE,
accounted for by the difference in corresponding amino-
acid residues, glutamic acid in Nrf2-ETGE and serine in
the case of mouse p62-KIR (S351). Importantly, this
serine residue is phosphorylated in response to selective
autophagy conditions such as impaired proteostasis,
bacterial infection, and mitochondrial depolarization
[29**e31]. X-ray crystal structural analysis of Keap1-
DC in complex with S351-phosphorylated p62-KIRwww.sciencedirect.compeptide showed that the phosphorylated KIR interacts
with the same number of amino acids as Nrf2-ETGE.
The affinity of phosphorylated p62-KIR for Keap1-DC is
5-fold lower than that of Nrf2-ETGE, but higher than
that of Nrf2-DLGex, indicating that phosphorylation of
p62 at S351 is sufficient for disruption of Keap1-
mediated Nrf2 ubiquitination (Figure 2).3. Physiological role of the p62-Keap1–Nrf2
axis
What stimuli activate the p62-mediatedNrf2? p62 serves
as an adaptor protein for selective autophagy: when se-
lective autophagic cargos such as damaged mitochondria
appear in the cytoplasm, they are ubiquitinated [4,5]. As
a result, adaptor proteins including p62 that bind to both
ubiquitin-chain and autophagosome-localized ATG8
family proteins assemble around the cargos [4,5]. At the
same time, some core ATG proteins such as FIP200,
indispensable for early autophagosome biogenesis, also
recognize the ubiquitinated targets [32], initiating the
process of autophagosome formation around the targets.
During this process, Ser407, located at the UBA domain
of p62, is initially phosphorylated by ULK1 kinase,
which is necessary in the early steps of autophagosome
biogenesis [33]. This phosphorylation destabilizes the
UBA dimer interface [34] and subsequently casein
kinase 2 (CK2), TANK-binding kinase 1 (TBK1), or
ULK1 phosphorylates Ser403 of the UBA domain
[33,35,36], which increases the binding affinity of
p62 to the ubiquitin-chain. Consequently, p62 is trans-
located to the ubiquitinated cargos and then phosphor-
ylated at Ser349 (corresponding to the mouse S351-
phosphorylated form) by mTORC1, and Keap1 is
sequestered into the ubiquitinated cargos, resulting in
Nrf2-activation [29**,30]. Finally, the ubiquitinated
cargos, together with phosphorylated p62 and Keap1, are
degraded by autophagy [27,29**,37**]. Sestrin2 forms a
ternary complex with p62 and Keap1, acting as a scaffold
protein for the p62-mediated autophagy of Keap1 [38*].
The major stress response pathways, the Keap1eNrf2
system and selective autophagy, are coupled to each
other through the phosphorylation of p62 (Figure 3).
Notably, because p62 is a target of Nrf2 [39,40**], a
feedback loop is present in the p62-Keap1eNrf2 axis.
Recently, it was reported that Lys7 of PB1 domain of p62
is ubiquitinated by TRIM21, which prevents p62-
aggregation and subsequent Keap1-sequestration onto
the aggregate structures [41**]. Thus, TRIM21 nega-
tively regulates the p62-Keap1eNrf2 axis.
Most autophagy-related genes are well conserved among
eukaryotes, but p62, Nrf2, Keap1, and TRIM21 are not.
p62 is conserved among metazoans but not in plants and
fungi, and KIR appears only from vertebrates. In
Caenorhabditis elegans, accumulation of damaged or su-
perfluous mitochondria causes oxidative stress that ac-
tivates SKN-1, a homolog of mammalian Nrf2, to induceCurrent Opinion in Toxicology 2016, 1:54–61
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Canonical and non-canonical Keap1–Nrf2 pathways. Keap1 dimers interact with the DLGex and the ETGE of Nrf2 through their Kelch b-propeller do-
mains. Nrf2 is therefore constantly ubiquitinated and degraded by the 26S proteasome. Under stress conditions, certain cysteine residues of Keap1 are
modified by reactive oxygen species and electrophiles in the canonical Keap1–Nrf2 pathway, followed by the dissociation of Nrf2 from Keap1. In non-
canonical Keap1–Nrf2 pathway, Ser349 phosphorylated p62 (p-STGE) competitively binds to Keap1, thereby dissociating the Nrf2 from Keap1.
Consequently, stabilized Nrf2 translocates to the nucleus by each pathway, and then together with a small Maf protein, induces its targets, which include
various cytoprotective genes. ARE: antioxidant response element.
56 Oxidative Toxicologythe coordinated expression of mitochondrial biogenesis
and mitophagy genes to preserve mitochondrial quality
[42]. Besides the SKN-1 function committed to anti-
oxidant response and autophagy, Keap1 is absent in C.
elegans. In Drosophila melanogaster, the gene expressions of
both Atg8a and Ref(2)P, which code mammalian homo-
logs LC3 and p62, are regulated by CncC, a mammalian
Nrf2 homolog, and therefore activation of CncC induces
autophagy [43]. Remarkably, while Ref(2)P does not
have the ability to interact with Keap1, Atg8a interacts
directly with Keap1 to modulate its levels through
autophagy, regulating the CncC activity [43]. TRIM21 is
conserved in vertebrates, and the gene expression is
regulated by interferons, a family of secreted proteins
that exert antiviral and immunomodulatory activities
[44]. These growing lines of evidence imply that gen-
eration of de novo gene products and interaction net-
works during evolution have provided autophagy with a
sophisticated p62 mediated Keap1eNrf2 pathway.4. Pathophysiological role of p62-
Keap1–Nrf2 axis in autophagy-deficient
mouse livers
Liver-specific autophagy-deficient mice (e.g., Atg7flox/flox;
Albumin-Cre) exhibit severe liver enlargement and liver
injury, accompanied by hepatic ballooning and monocyte
infiltration [45]. Due to defective autophagy, aggregateCurrent Opinion in Toxicology 2016, 1:54–61structures positive for S351-phosphorylated p62 and
Keap1 form in the cytoplasm of mutant livers
[29**,46*]. As a result, loss of autophagy usually causes
constant Nrf2-activation, which is abrogated by simul-
taneous loss of p62 [25**]. Remarkably, phenotypes
observed in single Atg7- or Atg5-deficient livers are
almost recovered by additional loss of p62 and of Nrf2,
even with defective autophagy [11*,47*], implying that
constitutive activation of Nrf2 is a primary cause of liver
impairment. However, because loss of Keap1 in mouse
hepatocytes leads to only mild liver abnormality [48],
the phenotypes detected in autophagy-deficient livers
cannot be attributed solely to Nrf2 activation. A feasible
explanation is that the collapse of the balance between
the synthesis (Nrf2-dependent robust protein synthe-
sis) and degradation of cellular proteins (global turnover
of cytoplasmic proteins through autophagy) could result
in the appearance of destructive phenotypes.
Long-term suppression of autophagy in mouse livers
causes tumorigenesis at 100% incidence [49*,50*].
Microtumors developed randomly throughout the liver
of 7e9-month-old mutant mice, increasing in size and
number with age. The tumors in autophagy-deficient
livers are in most cases well-demarcated with little
fibrous capsule, composed of irregular hepatic plate
with tumor cells showing large nuclear cytoplasmicwww.sciencedirect.com
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feedback loop is present in the p62-Keap1–Nrf2 axis. Keap1 is degraded together with the autophagic cargo. Note that TRIM21, a ubiquitin E3 ligase,
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The p62-Keap1–Nrf2 axis Katsuragi et al. 57ratio and occasional nuclear atypia, which are patho-
logically diagnosed as hepatocellular adenoma. Such
tumorigenesis is probably triggered not only by mito-
chondrial dysfunction followed by genome instability,
but also chronic inflammation, all of which are observed
in liver-specific autophagy-deficient mice [49*,50*].www.sciencedirect.comThe p62-Keap1eNrf2 axis is also likely to participate
in tumor development in autophagy-deficient mouse
livers. While tumor development in Atg7flox/flox; Albu-
min-Cre is suppressed markedly by concomitant loss of
p62, tumorigenesis is still observed [50*]. Meanwhile,
the fibrosis and tumorigenesis observed in Atg5 flox/flox;Current Opinion in Toxicology 2016, 1:54–61
58 Oxidative ToxicologyAlbumin-Cre is completely abrogated by additional loss
of Nrf2 [47*]. These lines of evidence imply that while
the p62-Keap1eNrf2 axis is involved in tumor pro-
gression, the canonical Keap1eNrf2 pathway plays an
important role in tumorigenesis under an autophagy-
deficient background.5. Pathophysiological role of p62-
Keap1–Nrf2 axis in hepatocellular
carcinoma
Like autophagy-deficient mouse livers, p62-positive
structures called MalloryeDenk bodies and hyaline
bodies have been identified in several cases of human
hepatocellular carcinoma (HCC) [13,14], and they
contained both the S349-phosphorylated form and
Keap1 [29**]. In particular, prominent accumulation
of the phosphorylated form as well as Nrf2-activation
was observed in HCC positive for Hepatitis C virus
(HCV) [46*]. Knockout of p62 in hepatocellular car-
cinoma cells, Huh1 cells, which express S349-
phosphorylated p62 at very high level, decreased
their proliferative activity in xenograft assay, which
was restored by introduction of S349-phosphorylation
mimetic (S349E) p62, but not the phosphorylation
defective (S349A) p62 [29**]. Nrf2-activation en-
gages in not only redox signaling but also cancer
metabolism. Nrf2 positively regulates the gene
expression of enzymes involved in pentose phosphate
pathway, purine-nucleotide syntheses, glutathione
syntheses, and glutaminolysis, and thus this tran-
scription factor’s activity can redirect glucose and
glutamine into anabolic pathways, in particular in lung
cancer cells harboring activated phosphatidylinositol
3-kinase (PI3K)-Akt, which promotes proliferation
[51]. The p62-Keap1eNrf2 axis also promotes malig-
nancy of HCC through similar, but not the same,
metabolic reprogramming, namely enhanced UDP-
glucuronate and glutathione production, which stim-
ulate growth of HCC and provide HCC cells with
tolerance to anti-tumor drugs [46*]. p62 over-
production in cancer precursor cells of mouse liversFigure 4
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Positive feedback
c-Myc
P
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Role of the p62-Keap1–Nrf2 axis in hepatocellular carcinoma. In p62-accumu
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Current Opinion in Toxicology 2016, 1:54–61also drives tumorigenesis of HCC via activation of
both mTORC1 and Nrf2 [52*] (Figure 4).
How does p62 accumulate in HCC cells? While auto-
phagosome formation is induced by infection of HCV,
fusion between autophagosomes and the lysosome is
suppressed to promote viral replication on or around
autophagosomes [53], resulting in decreased autophagy-
flux, and followed by accumulation of p62. Even in other
liver diseases including alcoholic liver disease, nonalco-
holic fatty liver and nonalcoholic steatohepatitis, auto-
phagy seems to be impaired, leading to p62
accumulation [54]. Because p62 is a stress-inducible
protein whose expression is regulated by Nrf2
[39,40**], chronic inflammation in patients would also
cause up-regulation of p62. Several cancers, including
HCC, frequently have somatic mutations of either Nrf2
or Keap1 [55e57], which cause alteration or impairment
of the Keap1eNrf2 interaction, followed by persistent
activation of Nrf2. Even in the absence of these somatic
mutations, Nrf2 is activated in certain types of cancer
and utilized for growth. For instance, Keap1 is succiny-
lated by the fumarate accumulated in type 2 papillary
renal cell carcinomas that carry mutations in fumarate
hydratase [58,59], leading to hyperactivation of Nrf2.
Therefore, p62 protein should accumulate in tumor cells
harboring mutations of either Nrf2 or Keap1, as well as in
the renal cell carcinomas with succinylated Keap1,
because Nrf2 positively regulates the gene expression of
p62. Considering that the overproduction of p62 pro-
teins is enough to stimulate S349-phosphorylation
[29**], p62 would inactivate normal Keap1 protein
synthesized from the Keap1-allele without the muta-
tion, leading to a vicious circle of Nrf2 activation in the
tumor cells. Accordingly, it is plausible that p62-
mediated Nrf2 activation occurs in various types of
tumor cells in addition to HCV-positive HCC.6. Concluding remarks
Various mutations of p62 have been identified in pa-
tients with Paget’s disease of bone (PDB), amyotrophicNrf2 Metabolic reprogramming
Anti-cancer drug resistance 
Various stress resistance 
Growth stimulation
lated HCC cells, mTORC-dependent phosphorylation of S349 (pS349)
tion and Nrf2 activation. The p62-Keap1–Nrf2 axis positive feedback loop
d mTORC1 activation causes hyper activation of c-Myc. The activation of
ng and thus contributes to not only tumorigenesis in HCC progenitor cells
www.sciencedirect.com
The p62-Keap1–Nrf2 axis Katsuragi et al. 59lateral sclerosis (ALS), and frontotemporal lobar
degeneration (FTLD) [60]. Moreover, p62 has been
identified as a pathogenic target of 5q copy number
gains in kidney cancer [61]. In addition to HCC, the
accumulation of S349-phosphorylated p62 was also
recently found in brains of patients with Alzheimer’s
disease [62,63] and in endothelial cells infected with
Kaposi’s sarcoma-associated herpesvirus [64]. These
mutations and modification may be accompanied by
alteration or ablation of p62-binding partner(s) such as
Keap1 and LC3, raising the possibility that Nrf2-activity
is dysregulated in the aforementioned diseases. Further
analysis is needed into whether pathogenesis in patients
with p62 mutations and modification is driven by Nrf2-
dysregulation.
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